Latest / Lung Cancer Considered
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.
Latest / Lung Cancer Considered
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC
The skinny isn't ready yet — notes appear once the transcript is processed.